[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100406989":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":22,"centralContacts":26,"locations":32,"responsibleParty":48,"collaborators":51,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":61,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":10,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Stanford University","OTHER",[8,13],{"label":9,"type":10,"description":10,"interventionNames":11},"COVID-19 participants",null,[12],"Biological: Flu shot",{"label":14,"type":10,"description":10,"interventionNames":15},"Control participants",[12],[17],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":10},"BIOLOGICAL","Flu shot","All participants will receive a single shot of the flu vaccine",[9,14],[23],{"name":24,"affiliation":5,"role":25},"Sayantani Sindher, MD","PRINCIPAL_INVESTIGATOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"SNP Center Inquiry","CONTACT","(650) 521-7237","snpcenterallergy_inquiry@stanford.edu",[33],{"facility":5,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"RECRUITING","Palo Alto","California","94304","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-122.14302,37.44188,{"lat":44,"lon":43},[47],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},{"type":25,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Sayantani B. Sindher","Associate Professor of Medicine",[52],{"name":53,"class":54},"National Institute of Allergy and Infectious Diseases (NIAID)","NIH","100406989","understanding-immunity-to-the-flu-vaccine-in-covid-19-patients-100406989",false,"NCT04579588","Understanding Immunity to the Flu Vaccine in COVID-19 Patients","Inclusion Criteria:\n\n* Age 9 through 64 years\n* Diagnosed with COVID-19 at least 2 months prior enrollment\n* Patients with or without obesity, diabetes, chronic fatigue and\u002For long term COVID-19 symptoms\n* Patients without COVID-19 diagnosis for controls\n\nExclusion Criteria:\n\n* Received the influenza vaccine less than 4 months ago\n* Pregnant or lactating\n* Patients with special risks attendant to venipuncture\n* Use of immunomodulatory medications that may impact vaccine immune response per clinician's judgment\n* Contraindication to the flu vaccine\n* Immunodeficiency or autoimmune disease that may impact vaccine immune responses per clinician's judgement",true,"ALL","9 Years","64 Years",{"count":66,"type":67},230,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.",[71,72,73],"Corona Virus Infection","Flu Vaccine","Immunity","2026-03-16",{"date":76,"type":77},"2026-03-18","ACTUAL",{"date":79,"type":77},"2020-10-29",{"date":81,"type":67},"2028-04",{"name":5,"class":6},1]